Nikole E. Kimes, Ph.D. is Chief Executive Officer and co-founder of Siolta Therapeutics, a clinical-stage biotech company located in the San Francisco Bay Area. Siolta is developing novel microbiome-based therapeutics and diagnostics for the prevention and treatment of chronic inflammatory diseases, starting with atopic diseases. Dr. Kimes leads the executive, clinical and scientific teams, working with a talented team of scientists and clinicians, blending microbiology, immunology, bioinformatics, and clinical operations expertise to leverage microbiome data for the improvement of patient stratification and development of precision microbial therapeutics. An inventor of Siolta's technology, her research in co-founder Dr. Susan Lynch's lab at UCSF provided the foundation from which the translational research program at Siolta Therapeutics has developed.